Press Releases

and/or
567 News Releases found
Nikolaus Schultz, PhD
Pivotal Memorial Sloan Kettering Cancer Center Study Provides Insights into the Genomic Basis of Cancer Metastasis

A new study from Memorial Sloan Kettering Cancer Center (MSK) provides important insights into cancer metastasis.  
Ghassan Abou-Alfa, MD
Immunotherapy Combination Significantly Improves Overall Survival for People with Advanced Liver Cancer Compared with Current Standard of Care

New study results found that patients who received a combination of the immunotherapy drugs durvalumab and tremelimumab significantly improved overall survival
MSK Awards & Appointments January 2022

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Rémy Evard
Memorial Sloan Kettering Cancer Center Appoints Rémy Evard as Chief Digital Officer and Head of Technology

Memorial Sloan Kettering Cancer Center (MSK) today announced that Rémy Evard has joined as its new Chief Digital Officer and Head of Technology.
Fiona and Stanley Druckenmiller
Memorial Sloan Kettering Cancer Center Announces the Creation of the Fiona and Stanley Druckenmiller Presidential Innovation Fund

Longtime donors Fiona and Stanley Druckenmiller have contributed a transformative gift of $100 million to MSK through their foundation. The gift will be used to launch the Fiona and Stanley Druckenmiller Presidential Innovation Fund.
MSK Awards & Appointments December 2021

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
Gilles Salles
MSK Chief of the Lymphoma Service Gilles Salles Presents Promising New Treatment for Patients with Diffuse Large B-Cell Lymphoma

The research was published in the New England Journal of Medicine and presented at the American Society of Hematology (ASH) Annual Meeting and Exposition.
Andrea Barrio, MD
MSK Experts Shine a Light on the Impact of Race and Ethnicity on Breast Cancer Related Lymphedema

Researchers found that Black race was the strongest predictor of lymphedema development with a 3.5-fold increased incidence of lymphedema in Black women compared to White women.
Saad Usmani, MD
Saad Usmani Named Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center

Saad Usmani, MD, has been named Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center.
MSK and SKI's Highly Cited Researchers.
Memorial Sloan Kettering Cancer Center Tops Prestigious List of Highly Cited Researchers

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that it is ranked among the top 20 organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute for Scientific Information at Clarivate.